Winton Group’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $452K | Sell |
1,160
-6,203
| -84% | -$2.62M | 0.01% | 741 |
|
|
2026
Q1 | $3.48M | Buy |
+7,363
| New | +$3.71M | 0.12% | 226 |
|
|
2025
Q2 | – | Sell |
-21,966
| Closed | -$7.59M | – | 894 |
|
|
2025
Q1 | $7.59M | Buy |
21,966
+21,065
| +2,338% | +$6.77M | 0.46% | 29 |
|
|
2024
Q4 | $270K | Buy |
+901
| New | +$315K | 0.02% | 533 |
|
|
2024
Q3 | – | Sell |
-679
| Closed | -$218K | – | 693 |
|
|
2024
Q2 | $218K | Sell |
679
-3,331
| -83% | -$1.08M | 0.01% | 526 |
|
|
2024
Q1 | $1.34M | Buy |
+4,010
| New | +$1.23M | 0.09% | 175 |
|
|
2023
Q4 | – | Sell |
-1,361
| Closed | -$335K | – | 784 |
|
|
2023
Q3 | $335K | Sell |
1,361
-5,136
| -79% | -$1.41M | 0.03% | 510 |
|
|
2023
Q2 | $1.97M | Sell |
6,497
-6,954
| -52% | -$1.93M | 0.17% | 108 |
|
|
2023
Q1 | $3.55M | Buy |
13,451
+10,473
| +352% | +$2.66M | 0.22% | 88 |
|
|
2022
Q4 | $715K | Sell |
2,978
-47
| -2% | -$10.5K | 0.05% | 524 |
|
|
2022
Q3 | $556K | Buy |
+3,025
| New | +$603K | 0.04% | 610 |
|
|
2022
Q2 | – | Sell |
-5,919
| Closed | -$1.48M | – | 996 |
|
|
2022
Q1 | $1.48M | Buy |
+5,919
| New | +$1.49M | 0.08% | 342 |
|
|
2021
Q4 | – | Sell |
-1,160
| Closed | -$282K | – | 1177 |
|
|
2021
Q3 | $282K | Sell |
1,160
-799
| -41% | -$195K | 0.02% | 1123 |
|
|
2021
Q2 | $405K | Sell |
1,959
-3,054
| -61% | -$622K | 0.02% | 1036 |
|
|
2021
Q1 | $944K | Buy |
5,013
+309
| +7% | +$54.5K | 0.05% | 504 |
|
|
2020
Q4 | $774K | Sell |
4,704
-3,201
| -40% | -$468K | 0.06% | 547 |
|
|
2020
Q3 | $986K | Buy |
+7,905
| New | +$978K | 0.03% | 835 |
|
|
2020
Q2 | – | Sell |
-13,550
| Closed | -$1.22M | – | 1499 |
|
|
2020
Q1 | $1.22M | Buy |
+13,550
| New | +$1.75M | 0.03% | 723 |
|
|
2019
Q4 | – | Sell |
-3,694
| Closed | -$445K | – | 1639 |
|
|
2019
Q3 | $445K | Sell |
3,694
-5,140
| -58% | -$664K | 0.01% | 1130 |
|
|
2019
Q2 | $1.19M | Sell |
8,834
-106,696
| -92% | -$13.5M | 0.02% | 370 |
|
|
2019
Q1 | $15.1M | Sell |
115,530
-405
| -0.3% | -$54.4K | 0.3% | 125 |
|
|
2018
Q4 | $14.4M | Sell |
115,935
-89,143
| -43% | -$12M | 0.31% | 121 |
|
|
2018
Q3 | $28.5M | Buy |
205,078
+199,135
| +3,351% | +$24.8M | 0.6% | 30 |
|
|
2018
Q2 | $610K | Sell |
5,943
-1,011
| -15% | -$102K | 0.02% | 577 |
|
|
2018
Q1 | $675K | Buy |
6,954
+1,973
| +40% | +$191K | 0.02% | 648 |
|
|
2017
Q4 | $438K | Sell |
4,981
-97,096
| -95% | -$7.8M | 0.01% | 529 |
|
|
2017
Q3 | $8.12M | Buy |
102,077
+28,778
| +39% | +$2.31M | 0.26% | 100 |
|
|
2017
Q2 | $6.39M | Buy |
73,299
+40,981
| +127% | +$3.47M | 0.19% | 150 |
|
|
2017
Q1 | $2.88M | Buy |
32,318
+26,349
| +441% | +$2.2M | 0.08% | 243 |
|
|
2016
Q4 | $442K | Sell |
5,969
-4,645
| -44% | -$348K | 0.01% | 374 |
|
|
2016
Q3 | $803K | Buy |
+10,614
| New | +$813K | 0.01% | 317 |
|
Other funds holding HCA
Winton Group's HCA Position: Q2 2026 in Review
Winton Group reduced its HCA Healthcare (HCA) stake by 84% in Q2 2026, selling an estimated $2.62M and leaving 1,160 shares worth $452K. The position accounts for 0.01% of the portfolio, ranked #741.
Winton Group first reported a position in HCA in Q3 2016 and has held it in 31 quarters since. The position peaked at $28.5M in Q3 2018. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.
- Winton Group held 1,160 shares of HCA Healthcare worth $452K as of Q2 2026.
- Winton Group sold 6,203 HCA Healthcare shares in Q2 2026, an estimated $2.62M.
- HCA Healthcare made up 0.01% of Winton Group's portfolio in Q2 2026, its #741 holding.
- Winton Group first reported a position in HCA Healthcare in Q3 2016 and has held it in 31 quarters since.
- Winton Group's HCA Healthcare position peaked at $28.5M in Q3 2018.
- 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.
Based on Winton Group's 13F filing for Q2 2026, filed 7 Aug 2026.